 |
AstraZeneca
Transport mapping study
Description
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products.
Opportunities
In defining a new packaging and distribution strategy in Europe, Groenewout was asked to define the accompanying optimal European Supply Chain Footprint, with a focus on the number of warehouses and their respective locations.
Solution
Groenewout defined a number of European distribution scenarios (number and location of warehouses), on:
- operational logistics costs
- investment & transition costs
- delivery reliability and lead-times.
Benefits
- A proof of strategy that the anticipated future packaging facility structure did not lead to additional supply chain costs
- A number of quick-wins that lead to financial savings and/or customer service improvements when implemented.
Supply Chains Management
Pharmaceutical
Northwestern Europe |